PMID- 29856174
OWN - NLM
STAT- MEDLINE
DCOM- 20190731
LR  - 20190731
IS  - 1827-1642 (Electronic)
IS  - 1121-421X (Linking)
VI  - 65
IP  - 1
DP  - 2019 Mar
TI  - Single brand, fully-covered, self-expandable metal stent for the treatment of 
      benign biliary disease: when should stents be removed?
PG  - 63-69
LID - 10.23736/S1121-421X.18.02506-0 [doi]
AB  - The two most relevant endoscopic treatable benign biliary diseases (BBD) are 
      benign biliary strictures (BBSs) and biliary leaks (BLs), often associated with 
      high morbidity. The most common endoscopic treatment for biliary strictures 
      involves placement of multiple plastic stents (PSs), with or without balloon 
      dilation, followed by planned exchange of the stents. Thus, there continues to be 
      high interest in pursuing alternative endoscopic approaches that may achieve 
      better results with fewer interventions. In this setting, the use of a 
      fully-covered, self-expandable metal stent (FCSEMS) is an attractive alternative 
      to single or multiple PSs for the treatment of BBDs. A single metal stent can 
      remain in place for a longer period of time before removal; however, the maximum 
      time the stent can be remain in place is still not well defined. The aim of this 
      review is to determine the removal time of the TaeWoong(R) FCSEMS, placed for BBD. 
      According to our data analysis, considering the absence of loss of the covering 
      of the FCSEMS and of any adverse events during and after stent removal, leaving 
      the TaeWoong medical FCSEMS in situ for an 8 months' period seems to be 
      acceptable for benign biliary diseases. Further studies need to evaluate their 
      removability at 1 year.
FAU - Mangiavillano, Benedetto
AU  - Mangiavillano B
AD  - Unit of Gastrointestinal Endoscopy, Humanitas - Mater Domini, Castellanza, 
      Varese, Italy - b_mangiavillano@hotmail.com.
AD  - Humanitas University - Hunimed, Milan Italy - b_mangiavillano@hotmail.com.
FAU - Khashab, Mouen A
AU  - Khashab MA
AD  - Division of Gastroenterology and Hepatology, Johns Hopkins Hospital, Baltimore, 
      MD, USA.
FAU - Eusebi, Leonardo H
AU  - Eusebi LH
AD  - Unit of Gastroenterology, Department of Medical and Surgical Sciences, S. 
      Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
FAU - Tarantino, Ilaria
AU  - Tarantino I
AD  - Gastroenterology and Endoscopy Unit, Mediterranean Institute for Transplantation 
      and Advanced Specialized Therapies (IsMeTT), Palermo, Italy.
FAU - Bianchetti, Mario
AU  - Bianchetti M
AD  - Unit of Gastrointestinal Endoscopy, Humanitas - Mater Domini, Castellanza, 
      Varese, Italy.
FAU - Semeraro, Rossella
AU  - Semeraro R
AD  - Digestive Endoscopy Unit, Istituto Clinico Humanitas Research Hospital, Rozzano, 
      Milan, Italy.
FAU - Pellicano, Rinaldo
AU  - Pellicano R
AD  - Unit of Gastroenterology, Molinette Hospital, Turin, Italy.
FAU - Traina, Mario
AU  - Traina M
AD  - Gastroenterology and Endoscopy Unit, Mediterranean Institute for Transplantation 
      and Advanced Specialized Therapies (IsMeTT), Palermo, Italy.
FAU - Repici, Alessandro
AU  - Repici A
AD  - Humanitas University - Hunimed, Milan Italy.
AD  - Digestive Endoscopy Unit, Istituto Clinico Humanitas Research Hospital, Rozzano, 
      Milan, Italy.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20180531
PL  - Italy
TA  - Minerva Gastroenterol Dietol
JT  - Minerva gastroenterologica e dietologica
JID - 9109791
MH  - Biliary Tract Diseases/*therapy
MH  - Cholestasis/etiology/*therapy
MH  - Endoscopy, Digestive System
MH  - Humans
MH  - *Stents
EDAT- 2018/06/02 06:00
MHDA- 2019/08/01 06:00
CRDT- 2018/06/02 06:00
PHST- 2018/06/02 06:00 [pubmed]
PHST- 2019/08/01 06:00 [medline]
PHST- 2018/06/02 06:00 [entrez]
AID - S1121-421X.18.02506-0 [pii]
AID - 10.23736/S1121-421X.18.02506-0 [doi]
PST - ppublish
SO  - Minerva Gastroenterol Dietol. 2019 Mar;65(1):63-69. doi: 
      10.23736/S1121-421X.18.02506-0. Epub 2018 May 31.